金花股份

600080 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

3.1B ($451.1M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

585.0M

Net Income

73.6M

Gross Margin

N/A

Op. Margin

8.4%

Net Margin

12.6%

ROE

4.7%

ROA

3.7%

D/E

0.26

Dividend Yield

N/A

EPS

0.21

Current Ratio

2.13

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 金花股份

Ticker	600080
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业